The Microbiome Business & Science Briefing
MicrobimeTimes
Reporting on The Latest Microbiome Business & Scientific Developments
TRENDING
Prokarium: Leading the Evolution of Bacterial Immunotherapy, the Next Frontier in Cancer Treatment• Claude Discovers Novel Enzyme System with CRISPR-like Repeats• New Clinical Study Aims to Find Out if FMT capsules could help better manage anorexia• MaaT Pharma Provides Update on MaaT013 (Xervyteg®) Potential Development Plan Following CHMP Negative Opinion After Re-examination• Evvy Raises $40M Series B to Scale AI-Powered Precision Diagnostics & Care Platform for Women’s Health• Armata Pharmaceuticals Receives U.S. FDA Breakthrough Therapy Designation for AP-SA02•

Category: Pharma & Human Health

Viome acquires Habit from Campbell Soup Company
Finance

Viome acquires Habit from Campbell Soup Company

FEB 7, 2019
The Human Microbiome: A Global Overview of Clinical Trials Activity
Clinical & Manufacturing

The Human Microbiome: A Global Overview of Clinical Trials Activity

FEB 5, 2019
Modelling Holobiont Evolution for a Better Understanding of Symbiosis, Dysbiosis, and Human Health
Editor's Choice

Modelling Holobiont Evolution for a Better Understanding of Symbiosis, Dysbiosis, and Human Health

FEB 3, 2019
Industry Experts Gather to Discuss Standardization of Microbiome Studies
Pharma & Human Health

Industry Experts Gather to Discuss Standardization of Microbiome Studies

FEB 3, 2019
Probiotic Bifidobacterium Infantis M-63 Alleviates Mental Stress of Flood Victims
Biotics and Supplements

Probiotic Bifidobacterium Infantis M-63 Alleviates Mental Stress of Flood Victims

FEB 3, 2019
Publication of Data in Connection with 4D Pharma’s Immuno-Stimulant and Anti-Tumour Agent MRx0518
Oncology

Publication of Data in Connection with 4D Pharma’s Immuno-Stimulant and Anti-Tumour Agent MRx0518

FEB 3, 2019
Azitra’s Clinical Study of AZT-04 for Cosmetic Use Completes Enrolment
Pharma & Human Health

Azitra’s Clinical Study of AZT-04 for Cosmetic Use Completes Enrolment

FEB 1, 2019
Eagle Genomics Closes $3.5M Investment
Finance

Eagle Genomics Closes $3.5M Investment

JAN 31, 2019
4D Pharma Announces Publication of Data Highlighting Immuno-Stimulatory Properties of MRx0518
Pharma & Human Health

4D Pharma Announces Publication of Data Highlighting Immuno-Stimulatory Properties of MRx0518

JAN 29, 2019
Evelo Announces Dosing of First Patient in Phase 2a Clinical Trial in Patients with Metastatic Melanoma
Clinical & Manufacturing

Evelo Announces Dosing of First Patient in Phase 2a Clinical Trial in Patients with Metastatic Melanoma

JAN 29, 2019
Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For NASH
Clinical & Manufacturing

Second Genome Doses First Patient In Phase 2 Clinical Study Of SGM-1019 For NASH

JAN 24, 2019